Immusoft (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- January 03, 2019
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $20,000,000
Company Info
- Company Description
- Immusoft's mission is to treat diseases using its breakthrough technology platform called Immune System Programming (ISP™). The technology modifies a patient's B cells and instructs the cells to produce gene-encoded medicines (biologics). The B cells that are reprogrammed using ISP become miniature drug factories that are expected to survive in patients for many years.
- Market
- Healthcare
- Location
- Seattle, WA, USA
- Coinvestors
- Alexandria Venture Investments, Breakout Ventures, DEFTA Partners, Mesa Verde Venture Partners, RBV Capital